Cost to Bring a New Drug to Market is Now $2.6B

Nov 20, 2014

Tufts Center for the Study of Drug Development

According to a new study by the Tufts Center for the Study of Drug Development, the estimated cost of developing a new prescription medicine that gains marketing approval is now $2.6 billion.

The estimated cost is based on an average out-of-pocket cost of $1.4 billion and time costs of $1.2 billion.

In a study published in 2003, Tufts CSDD estimated the cost per approved new drug to be $802 million (which equates to about 1 billion 2013 dollars), based on average out-of-pocket costs of $403 million and capital costs of $401 million.

Read the Tufts press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments